Austrian Federal Office for Safety in Health Care Austrian Medicines and Medical Devices Agency

Procedures authorised in Austria

Name of product	CHMP-Opinion	Date of authorisation in Austria	Applicant Austria
Tamiflu IV Oseltamivir phosphate 100mg - Powder for solution for infusion	Yes	30.12.2010	Roche Austria GmbH E-Mail: austria.drarochecom Fax: +43 (0) 1 27739-254
IV Zanamivir 10 mg/ml - solution for infusion	Yes	10.09.2010	GlaxoSmithKline Pharma E-Mail: andrea.r.rohrauergskcom Tel.: +43 (0) 1 97075-519

Name of product

CHMP-Opinion

Date of authorisation

in Austria

Applicant Austria

Tamiflu IV
Oseltamivir phosphate
100mg - Powder for solution for infusion

30.12.2010

Roche Austria GmbH

Fax: +43 (0) 1 27739-254

IV Zanamivir 10 mg/ml - solution for infusion

10.09.2010

GlaxoSmithKline Pharma

Tel.: +43 (0) 1 97075-519

Created: 20.01.2011